Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendat ...

The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and ...

The country is considered the epicenter of the disease in the Americas, with epidemics reported over the years.

Six people have died from chikungunya on the French overseas department of Réunion Island since the start of the year, health ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...

The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose ...

Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...

Get Matt’s next trade alert free. Chikungunya virus is a mosquito-borne viral disease spread by the bites of infected Aedes ...